430
Participants
Start Date
May 31, 2015
Primary Completion Date
October 31, 2018
Study Completion Date
April 25, 2019
Ibrutinib
Gemcitabine
Nab-paclitaxel
ULB Hôpital Erasme, Brussels
Cliniques Universitaires Saint-Luc, Brussels
UZ Leuven, Leuven
C. H. U. Sart Tilman, Liège
Grand Hôpital de Charleroi, Gilly
Onkologische Schwerpunktpraxis Kurfuerstendamm, Berlin
Hôpital de la Timone, Marseille
Seoul National University Bundang Hospital, Seongnam-si
Azienda Ospedaliero Universitaria San Martino, Genova
Penn State University Milton S. Hershey Medical Center, Hershey
Ospedale San Raffaele, Milan
IEO Istituto Europeo di Oncologia, Milan
Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milan
Center for Cancer and Blood Disorders, Bethesda
Centre Georges François Leclerc, Dijon
CHU Besançon - Hôpital Jean Minjoz, Besançon
Hôpital Nord Franche Comté, Doubs
Fondazione IRCCS Policlinico San Matteo, Pavia
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
The Presbyterian Hospital, Charlotte
Hospital Clinico Universitario Virgen de la Victoria, Málaga
Gibbs Cancer Center, Spartanburg
Northwest Georgia Oncology Centers, PC, Marietta
University Cancer & Blood Center, LLC, Athens
CHU de Toulouse - Hôpital Rangueil, Toulouse
Groupe Hospitalier Saint André - Hôpital Saint André, Bordeaux
Bethesda Memorial Hospital, Boynton Beach
Florida Hospital Tampa, Tampa
IOV - Istituto Oncologico Veneto IRCCS, Padua
Oncology Specialties, PC; Clearview Cancer Institute, Huntsville
Hospital Universitario Virgen Macarena, Seville
Hospital Universitario Virgen del Rocio, Seville
University of Cincinnati Medical Center, Cincinnati
Investigative Clinical Research of Indiana, Indianapolis
Saint Joseph Mercy Health System, Chelsea
Sparrow Regional Cancer Center, Lansing
Universitaetsklinikum Koeln, Cologne
Azienda Ospedaliero Universitaria Pisana, Pisa
Chonnam National University Hwasun Hospital, Hwasun
Joliet Oncology-Hematology Associates, LTD, Joliet
Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt am Main
Ingalls Memorial Hospital Cancer Research Center, Harvey
Centre Paul Strauss, Strasbourg
Nebraska Medicine - Peggy D. Cowdery Patient Care Center, Omaha
Mary Bird Perkins Cancer Center, Baton Rouge
Our Lady of the Lake Physician Group, Baton Rouge
IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo
Universitaetsklinikum Tuebingen, Tübingen
Groupe Hospitalier Pitie-Salpetriere, Paris
Hôpital Saint-Antoine, Paris
Scott & White Memorial Hospital, Temple
Istituto Nazionale Tumori Fondazione G. Pascale, Napoli
Arizona Center for Cancer Care, Avondale
CHU Poitiers - Hôpital la Milétrie, Poitiers
Universitaetsklinikum Ulm, Ulm
Cedars Sinai Medical Center, Los Angeles
Moores UCSD Cancer Center, La Jolla
St. Mary's Medical Center, Daly City
MultiCare Health System Institute for Research and Innovation, Tacoma
Wenatchee Valley Hospital & Clinics, Wenatchee
Norwalk Hospital, Norwalk
Eastern Connecticut Hematology/Oncology Assoc., Norwich
Berkshire Hematology Oncology Services at Berkshire Medical Center Cancer and Infusion Center, Pittsfield
Centre Antoine Lacassagne, Nice
Universitaetsklinikum Leipzig AoeR, Leipzig
Gemeinschaftspraxis Haematologie und Onkologie, Dresden
Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona
Seoul National University Hospital, Seoul
Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Korea University Guro Hospital, Seoul
ICO l´Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Hospital del Mar, Barcelona
Specialist, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic i Provincial de Barcelona, Barcelona
Derriford Hospital, Plymouth
Broomfield Hospital, Chelmsford
The Christie, Manchester
Southampton General Hospital, Southampton
The Clatterbridge Cancer Centre, Liverpool
Royal Marsden Hospital, Sutton
Royal Free Hospital, London
Lead Sponsor
Pharmacyclics LLC.
INDUSTRY